Stay informed with the latest litigation news. Explore now

IP Verse

Heterodimers Of Glutamic Acid - EP3699162B1

EP3699162

MOLECULAR INSIGHT PHARMACEUTICALS
Application Number
EP19214298A
Filing Date
Nov 7, 2007
Status
Granted And Under Opposition
May 27, 2022
Grant Date
Jun 29, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3335736B1

Bibliography

The patent EP3699162B1 was granted to Molecular Insight Pharmaceuticals on Jun 29, 2022 following the initial filing on Nov 7, 2007 under the application number EP19214298A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

TELIX INNOVATIONSJan 10, 2023ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents